Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis-Reference-Cited by-同舟云学术

Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis

Published:2023-02 Issue:2 Volume:23 Page:127-137
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Hasegawa Ken,Wei Andrew H^ORCID,Garcia-Manero Guillermo,Daver Naval G,Rajakumaraswamy Nishanthan,Iqbal Shahed,Chan Rebecca J,Hu Hao,Tse Preston,Yan Jiajun^ORCID,Zoratti Michael J^ORCID,Xie Feng,Sallman David A

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference66 articles.

1. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies];Aul;Med Klin (Munich),2002

2. The myelodysplastic syndromes;Sekeres;Expert Opin Biol Ther,2007

3. Myelodysplastic syndromes: from pathogenesis and prognosis to treatment;Fenaux;Semin Hematol,2004

4. Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010;Sekeres;J Natl Compr Canc Netw,2011

5. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology;Disperati;Leuk Res,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers;Clinical Lymphoma Myeloma and Leukemia;2024-06

2. Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2023-12

3. Advances in myelodysplastic syndromes: promising novel agents and combination strategies;Expert Review of Hematology;2023-01-02